Metrikler
Yayın
11
Açık Erişim
2
BM Sürdürülebilir Kalkınma Amaçları
Akademik Faaliyetlere Dayalı Araştırma Alanları
Avesis Araştırma Alanları
WoS Araştırma Alanları
Scopus Araştırma Alanları
Makaleler
Tümü (11)
SCI-E, SSCI, AHCI (11)
SCI-E, SSCI, AHCI, ESCI (11)
Scopus (11)
2012
20121. Ifosfamide and Doxorubicin Combination Chemotherapy for Recurrent Nasopharyngeal Carcinoma Patients
ŞENER DEDE D., AKSOY S., CENGİZ M., Gullu İ. H., Altundag K.
ASIAN PACIFIC JOURNAL OF CANCER PREVENTION
, cilt.13, sa.5, ss.2225-2228, 2012 (SCI-Expanded, Scopus)
2010
20102. Blood ABO groups and risk of breast cancer
ŞENER DEDE D., AKSOY S., DİZDAR Ö., Cerci P., Gullu İ. H., Ozisik Y., et al.
MEDICAL ONCOLOGY
, cilt.27, sa.4, ss.1433, 2010 (SCI-Expanded, Scopus)
2010
20103. Serum levels of CEA and CA 15-3 in triple-negative breast cancer at the time of diagnosis
ŞENER DEDE D., ARSLAN Ç., Altundag K.
MEDICAL ONCOLOGY
, cilt.27, sa.4, ss.1429, 2010 (SCI-Expanded, Scopus)
2010
20104. Probable sorafenib-induced reversible encephalopathy in a patient with hepatocellular carcinoma
Dogan E., AKSOY S., ARSLAN Ç., ŞENER DEDE D., Altundag K.
MEDICAL ONCOLOGY , cilt.27, sa.4, ss.1436-1437, 2010 (SCI-Expanded, Scopus)
2010
20105. Other malignancies in patients with breast cancer: a single institute experience
Dogan E., AKSOY S., DİZDAR Ö., ŞENER DEDE D., ARSLAN Ç., Ozisik Y., et al.
MEDICAL ONCOLOGY
, cilt.27, sa.4, ss.1434-1435, 2010 (SCI-Expanded, Scopus)
2010
20106. Clinical and pathological characteristics of breast cancer patients with history of cesarean delivery
Kalan I., Turgut D., AKSOY S., ŞENER DEDE D., DİZDAR Ö., Ozisik Y., et al.
BREAST
, cilt.19, sa.1, ss.67-68, 2010 (SCI-Expanded, Scopus)
2009
20097. Chemotherapy in Older Women with Breast Cancer
DİZDAR Ö., ŞENER DEDE D., Altundag K.
NEW ENGLAND JOURNAL OF MEDICINE
, cilt.361, sa.10, ss.1023, 2009 (SCI-Expanded, Scopus)
2008
20088. Pure or mixed-type invasive lobular carcinoma?
Bulut N., ŞENER DEDE D., Sari E., Altundag K.
HUMAN PATHOLOGY , cilt.39, sa.7, ss.1121, 2008 (SCI-Expanded, Scopus)
2008
20089. Dasatinib may also inhibit c-Kit in triple negative breast cancer cell lines
DİZDAR Ö., ŞENER DEDE D., Bulut N., Altundag K.
BREAST CANCER RESEARCH AND TREATMENT
, cilt.107, sa.2, ss.303, 2008 (SCI-Expanded, Scopus)
2007
200710. Aromatase inhibitor-associated arthralgias: Pathogenesis, frequency and management
Altundag K., ŞENER DEDE D., Harputluoglu H., Gullu İ. H.
JOINT BONE SPINE , cilt.74, sa.6, ss.662-663, 2007 (SCI-Expanded, Scopus)
2007
200711. Potential molecular targeted therapies in the management of the basal-like subtype of breast cancer
KURT M., Harputluoglu H., ŞENER DEDE D., GÜLLÜ İ. H., Altundag K.
BREAST
, cilt.16, sa.2, ss.111-112, 2007 (SCI-Expanded, Scopus)